Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
FDA
May 19, 2024, 15:15 |
Insight
Vivek Subbiah: Precision Oncology NTRK - How to you pick needles from the haystack?
Vivek Subbiah shared on LinkedIn: "Pleased to share our editorial American Cancer Society Journal Cancer. TRKing…
May 19, 2024, 13:53 |
Cancer Types
Merkel Cell Carcinoma (MCC) in Adults: What patients should know about
Merkel Cell Carcinoma (MCC) is a rare and aggressive form of skin cancer that primarily affects the skin's outer…
May 19, 2024, 10:55 |
Insight
Dhruba Deb: The 8 SCLC projects Lung Cancer Research Foundation recently funded
Dhruba Deb, Senior Director of Research and Administration at Lung Cancer Research Foundation, shared on…
May 18, 2024, 09:18 |
Blog
Vivek Subbiah: KRAS inhibition reminds me of this Greek restaurant KRASi in Boston
Vivek Subbiah shared a post on X/Twitter: ''Pleased to share our editorial in an ASCO journal.…
May 17, 2024, 14:09 |
Societies
Tatiana Prowell: Liquid biopsy - Is there benefit? We don't know
Tatiana Prowell shared on X: . "Liquid biopsy has not been shown to improve outcome…
May 16, 2024, 16:51 |
Insight
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
In the fast-growing field of oncology, we are witnessing significant advances in several treatment modalities…
May 16, 2024, 11:47 |
Insight
Aakash Desai: We explored the molecular characteristics of KRAS wildtype PDAC
Aakash Desai, Assistant Professor at O'Neal Comprehensive Cancer Center at UAB, shared on LinkedIn: "In…
May 15, 2024, 14:47 |
Drugs
Hagop Kantarjian: New research is expanding inotuzumab use into frontline, for MRD+, and in combination with blinatumomab
Nicholas Short, Associate Professor at the Department of Leukemia at MD Anderson Cancer Center, shared…
May 15, 2024, 14:44 |
Blog
Maria Babak: Welcome to our May edition of Babak Monthly!
Maria Babak, Head of Drug Discovery Lab at City University of Hong Kong, shared a post…
May 15, 2024, 12:01 |
Blog
David Steensma: IND application for first type II JAK2 inhibitor to go into clinical trials
David Steensma, Chief Medical Officer at Ajax Therapeutics, shared a post by Ajax Therapeutics on X/Twitter:…
60
61
62
63
64
All:
950
Posts:
611 - 620
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 6
ASTRO24: 15 Posts Not To Miss From Day 4
Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024
Paper Alert! Cutaneous Metastases in Thyroid Cancer: A Comprehensive Review of 136 Cases
ASTRO 24: 15 Posts Not to Miss From Day 3
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube